Chirag Acharya

2.9k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Chirag Acharya is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Chirag Acharya has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Chirag Acharya's work include Multiple Myeloma Research and Treatments (18 papers), Peptidase Inhibition and Analysis (5 papers) and T-cell and B-cell Immunology (4 papers). Chirag Acharya is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Peptidase Inhibition and Analysis (5 papers) and T-cell and B-cell Immunology (4 papers). Chirag Acharya collaborates with scholars based in United States, China and Italy. Chirag Acharya's co-authors include Yu‐Tzu Tai, Nikhil C. Munshi, Kenneth C. Anderson, Gang An, Xiaoyan Feng, Mike Zhong, Kenneth Wen, Antonia Cagnetta, Paul G. Richardson and Michele Cea and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Chirag Acharya

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

2014 375 citations Yu‐Tzu Tai, Patrick A. Mayes et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chirag Acharya United States	14	855	820	583	344	263	29	1.5k
Marijn Bögels Netherlands	13	484 0.6×	279 0.3×	336 0.6×	505 1.5×	209 0.8×	20	1.1k
Lugui Qiu China	17	315 0.4×	397 0.5×	483 0.8×	222 0.6×	47 0.2×	125	1.0k
Antonella Gozzini Italy	22	408 0.5×	1.0k 1.3×	752 1.3×	147 0.4×	103 0.4×	75	1.7k
Evdoxia Hatjiharissi United States	21	649 0.8×	727 0.9×	724 1.2×	555 1.6×	207 0.8×	86	2.0k
Sheeba K. Thomas United States	24	889 1.0×	1.1k 1.4×	1.1k 1.9×	249 0.7×	84 0.3×	161	2.0k
Esther A. Obeng United States	12	303 0.4×	584 0.7×	1.2k 2.1×	252 0.7×	37 0.1×	33	1.8k
Yuhong Lu China	19	572 0.7×	282 0.3×	394 0.7×	456 1.3×	125 0.5×	55	1.1k
Lydie Crescence France	16	492 0.6×	221 0.3×	378 0.6×	292 0.8×	37 0.1×	31	1.1k
Ann Mohrbacher United States	14	679 0.8×	943 1.1×	661 1.1×	292 0.8×	281 1.1×	46	1.5k
Francesca Arruga Italy	20	312 0.4×	394 0.5×	502 0.9×	332 1.0×	25 0.1×	60	1.3k

Countries citing papers authored by Chirag Acharya

Since Specialization

Citations

This map shows the geographic impact of Chirag Acharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chirag Acharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chirag Acharya more than expected).

Fields of papers citing papers by Chirag Acharya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chirag Acharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chirag Acharya. The network helps show where Chirag Acharya may publish in the future.

Co-authorship network of co-authors of Chirag Acharya

This figure shows the co-authorship network connecting the top 25 collaborators of Chirag Acharya. A scholar is included among the top collaborators of Chirag Acharya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chirag Acharya. Chirag Acharya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Acharya, Prakrati, Chirag Acharya, & Juan Medaura. (2021). IgA Nephropathy Post COVID-19 Vaccination. Journal of the American Society of Nephrology. 32(10S). 89–89.

Acharya, Prakrati, Chirag Acharya, Charat Thongprayoon, et al.. (2021). Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 9(2). 39–39. 39 indexed citations

Thongprayoon, Charat, Caroline C. Jadlowiec, Napat Leeaphorn, et al.. (2021). Feature Importance of Acute Rejection among Black Kidney Transplant Recipients by Utilizing Random Forest Analysis: An Analysis of the UNOS Database. SHILAP Revista de lepidopterología. 8(11). 66–66. 9 indexed citations

Tai, Yu‐Tzu, Liang Lin, Lijie Xing, et al.. (2018). APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 33(2). 426–438. 66 indexed citations

Thongprayoon, Charat, Prakrati Acharya, Chirag Acharya, et al.. (2018). Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies. Osteoporosis International. 29(8). 1737–1745. 46 indexed citations

Mittal, Varun, et al.. (2017). Bleeding Events and Obstetric Complications of Pregnancy in Hospitalized Patients with Hemophilia: Results from Nationwide Inpatient Sample Database 2003-2011. Blood. 130. 2100–2100. 1 indexed citations

Mittal, Varun, et al.. (2017). Obstetric and Bleeding Complications in Pregnancy with Von Willebrand Disease: Results from Nationwide Inpatient Sample Database 2003-2011. Blood. 130. 3373–3373. 1 indexed citations

Lin, Liang, Lijie Xing, Chirag Acharya, et al.. (2017). CD8+ Anti-BCMA mRNA CAR T-Cells Effectively Kill Human Multiple Myeloma Cells In Vitro and In Vivo. Blood. 130. 3067–3067. 6 indexed citations

Feng, Xiaoyan, Li Zhang, Chirag Acharya, et al.. (2017). Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma. Clinical Cancer Research. 23(15). 4290–4300. 193 indexed citations

10.

Fulciniti, Mariateresa, Nicola Amodio, Antonia Cagnetta, et al.. (2016). miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth. Blood Cancer Journal. 6(1). e380–e380. 50 indexed citations

11.

An, Gang, Chirag Acharya, Xiaoyan Feng, et al.. (2016). Osteoclasts Promote Immune Suppressive Microenvironment in Multiple Myeloma: Therapeutic Implication. Blood. 128(22). 3303–3303. 8 indexed citations

12.

Shi, Lihui, Xiaoqi Qin, Huijun Wang, et al.. (2016). Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget. 8(12). 18792–18801. 81 indexed citations

13.

Tai, Yu‐Tzu, Chirag Acharya, Gang An, et al.. (2016). APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. Blood. 127(25). 3225–3236. 251 indexed citations

14.

An, Gang, Chirag Acharya, Shuhui Deng, et al.. (2014). Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment. Experimental Hematology. 43(3). 168–176.e2. 9 indexed citations

15.

An, Gang, Xiaoqi Qin, Chirag Acharya, et al.. (2014). Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients. Annals of Hematology. 94(2). 257–264. 50 indexed citations

16.

Tai, Yu‐Tzu, Chirag Acharya, Gang An, et al.. (2014). A Novel Anti-a Proliferation-Inducing Ligand Hapril.01A Monoclonal Antibody Targets Multiple Myeloma Cells in the Bone Marrow Microenvironment. Blood. 124(21). 2098–2098. 1 indexed citations

17.

Cagnetta, Antonia, Sophia Adamia, Chirag Acharya, et al.. (2014). Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. Leukemia Research. 38(6). 649–659. 32 indexed citations

18.

Jiang, Hua, Gang An, Chirag Acharya, et al.. (2014). SAR650984 (SAR) Directly Promotes Homotypic Adhesion-Related Multiple Myeloma (MM) Cell Death and SAR-Induced Anti-MM Activities Are Enhanced By Pomalidomide, More Potently Than Lenalidomide. Blood. 124(21). 2124–2124. 2 indexed citations

19.

Tai, Yu‐Tzu, Chirag Acharya, Mike Zhong, et al.. (2013). Constitutive B-Cell Maturation Antigen (BCMA) Activation In Human Multiple Myeloma Cells Promotes Myeloma Cell Growth and Survival In The Bone Marrow Microenvironment Via Upregulated MCL-1 and NFκB Signaling. Blood. 122(21). 681–681. 2 indexed citations

20.

Tai, Yu‐Tzu, Chirag Acharya, Mike Zhong, et al.. (2013). Novel Fc-Engineered Anti-B Cell Maturation Antigen-Monomethyl Auristatin F Antibody-Drug Conjugate (GSK2857916) Induces Potent and Selective Anti-Multiple Myeloma Activity Via Enhanced Effector Function and Direct Tumor Cell Killing. Blood. 122(21). 877–877. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact